Organogenesis Holdings Inc.ORGONASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +6.12% | +27.10% | -21.17% | -22.62% | +30.98% |
| Gross Profit Growth | +6.82% | +33.00% | -22.53% | -27.60% | +29.68% |
| EBITDA Growth | -23.18% | +33.10% | -11136.81% | +0.00% | +154.81% |
| Operating Income Growth | -22.46% | +0.00% | +0.00% | +0.00% | +232.06% |
| Net Income Growth | +289.36% | +0.00% | +0.00% | +0.00% | +74.90% |
| EPS Growth | +285.89% | +0.00% | +0.00% | +0.00% | +18.28% |
| EPS Diluted Growth | +288.61% | +0.00% | +0.00% | +0.00% | +19.44% |
| Weighted Average Shares Growth | +0.96% | +0.58% | -4.22% | -4.31% | -4.29% |
| Weighted Average Shares Diluted Growth | +0.38% | +0.23% | -4.22% | -4.31% | -2.30% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -48.04% | +3.05% | +0.00% | -793.82% | -64.59% |
| Free Cash Flow Growth | -43.05% | +3.94% | +0.00% | -1377.50% | -86.22% |
| Receivables Growth | +13.44% | +33.98% | +7.46% | +13.63% | +66.66% |
| Inventory Growth | -3.11% | -7.20% | +5.94% | +22.91% | +46.41% |
| Asset Growth | -3.53% | +8.23% | +1.94% | +4.05% | +14.24% |
| Book Value per Share Growth | -0.35% | +37.48% | +38.22% | +43.27% | +44.79% |
| Debt Growth | -13.88% | -63.71% | -64.07% | -63.84% | -62.10% |
| R&D Expense Growth | -1.20% | -2.04% | -16.94% | -33.31% | +27.81% |
| SG&A Expenses Growth | +11.79% | +20.32% | +0.26% | -3.57% | +10.35% |